Argentus Capital Management’s Gilead Sciences GILD Stock Holding History

Argentus Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-5,065	Closed	-$401K	–	172
2016 Q3	$401K	Sell	5,065 -1,203	-19%	-$97.7K	0.14%	193
2016 Q2	$523K	Sell	6,268 -3,920	-38%	-$348K	0.22%	120
2016 Q1	$941K	Buy	10,188 +1,864	+22%	+$168K	0.33%	77
2015 Q4	$842K	Sell	8,324 -20,542	-71%	-$2.14M	0.26%	97
2015 Q3	$2.83M	Sell	28,866 -11,445	-28%	-$1.27M	0.42%	62
2015 Q2	$4.72M	Buy	40,311 +2,533	+7%	+$277K	0.72%	37
2015 Q1	$3.71M	Buy	+37,778	New	+$3.84M	0.59%	43
2014 Q3	–	Sell	-11,348	Closed	-$941K	–	336
2014 Q2	$941K	Buy	+11,348	New	+$883K	0.25%	98

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Argentus Capital Management's GILD Position: Q4 2016 in Review

Argentus Capital Management sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 5,065 shares — an estimated $401K sold.

Argentus Capital Management first reported a position in GILD in Q2 2014 and held it in 8 quarters. The position peaked at $4.72M in Q2 2015. 1,572 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

Argentus Capital Management reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
Argentus Capital Management sold 5,065 Gilead Sciences shares in Q4 2016, an estimated $401K.
Argentus Capital Management first reported a position in Gilead Sciences in Q2 2014 and held it in 8 quarters.
Argentus Capital Management's Gilead Sciences position peaked at $4.72M in Q2 2015.
1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Argentus Capital Management's 13F filing for Q4 2016.